Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Kaken

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Kaken's Japan sales performance.

Roche’s Actemra approved for severe COVID-19 in Europe

Roche’s Actemra approved for severe COVID-19 in Europe

Actemra/RoActemra is a co-development between Roche and Chugai. It was first approved in Japan in April 2005 and is currently available in more than 110 countries worldwide.

Omicron prompts global action

Omicron prompts global action In fact, Japan has taken even stronger action, banning all foreigners from entering the country from 30 November.

CHMP rejects Kyowa Kirin’s Parkinson’s disease drug

CHMP rejects Kyowa Kirin’s Parkinson’s disease drug as we do in the US and Japan,” he added.

AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance

AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance The EU clearance comes after similar competition clearances in the US, Japan and other global regulatory agencies, AZ said in a statement.

AZ, HUTCHMED win first approval for MET inhibitor Orpathys in China

AZ, HUTCHMED win first approval for MET inhibitor Orpathys in China Japan’s medicines regulator.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
...
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...